The Bottom Line Retatrutide could mark the next chapter in metabolic medicine, an evolution that takes the success of Ozempic and Mounjaro even further
Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline
There has also been a lot of attention paid to the effects that GLP-1 drugs may have on the mind, particularly whether they increase suicidal thoughts
Medication source: Both U.S
Additionally, most reputable compounding pharmacies are halting production, meaning any compounded medications still available may come from less reliable or poorly regulated sources
References Gregg EW, Li Y, Wang J, Rios Burrows N, Ali MK, Rolka D, et al